FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

675 letters match. Newest first.

  1. Sperm Bank, Inc. dba Fertility Center of California

    FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.

    High risk
  2. Marshalls Traditional Healthcare CC

    Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.

    High risk
  3. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  4. Robbins Instruments, LLC

    Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.

    High risk
  5. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk
  6. Wuhu Nuowei Chemistry Co., Ltd.

    FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.

    High risk
  7. ISOThrive, Inc.

    ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.

    High risk
  8. Strukmyer LLC dba Strukmyer Medical

    Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.

    High risk
  9. Center for Instrumental Analysis of China Pharmaceutical University

    Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.

    High risk
  10. Sanofi

    FDA warned Sanofi subsidiary Genzyme over manufacturing quality failures at its Framingham, MA API plant.

    High risk
  11. COFISA - Conservas de Peixe da Figueira, S.A.

    FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

    High risk
  12. Duong Ha Processing Trading Seafood Company Limited

    FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.

    High risk
  13. Salt City Baking Company, LLC

    FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.

    High risk
  14. Hologic, Inc.

    FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.

    High risk
  15. Phillips Precision, Inc.

    FDA says Phillips Precision, a contract maker of orthopedic implants and instruments, violated device quality rules for cleaning and process controls.

    High risk
  16. Randox Laboratories Limited

    FDA warned Randox Laboratories over inadequate risk analysis and corrective actions for carryover errors in RX series analyzers.

    High risk
  17. Indoco Remedies Limited

    FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.

    High risk
  18. Bhargava Phytolab Private Limited

    FDA warns Bhargava Phytolab over drug and API current good manufacturing practice (CGMP) violations, including inadequate testing and sterility controls.

    High risk
  19. Viatris, Inc.

    FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.

    High risk
  20. Sombra Cosmetics, Inc.

    FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.

    High risk
  21. Anne’s Daye Ltd dba Tampon Innovations

    FDA says Anne’s Daye marketed CBD-coated tampons and vaginal screening kits without required device clearance or approval.

    High risk
  22. Loyd Sanabria Hernandez dba Avicola Santa Fe

    FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.

    High risk
  23. Rontis Hellas S.A.

    Rontis Hellas made Cronus HP PTA balloon catheters with an unproven EtO sterilization process and inadequate US adverse-event reporting procedures.

    High risk
  24. Micro Orgo Chem

    Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.

    High risk
  25. Mid America Pet Food LLC

    FDA warned Mid America Pet Food after Salmonella-linked recalls and found persistent contamination and animal-food safety-rule violations at its Texas plant.

    High risk
  26. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  27. Guangzhou Four E’s Scientific Co., Ltd.

    FDA warns Guangzhou Four E’s over CGMP failures for OTC drugs, including a sterile-labeled product with inadequate sterility assurance.

    High risk
  28. Purcell International

    Purcell International imported cinnamon apple sauce linked to lead contamination without adequate foreign supplier verification.

    High risk
  29. Caribbean Produce Exchange, LLC

    Caribbean Produce Exchange lacked required foreign supplier verification records for imported WanaBana apple cinnamon puree linked to lead recall.

    High risk
  30. Knickerbocker 365 Inc.

    FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.

    High risk
  31. Zhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.

    FDA warns Zhejiang Uniquality over inadequate OTC drug component testing and quality oversight; import alert issued.

    High risk
  32. Calavo Growers, Inc.

    Calavo Growers' papayas are adulterated because contracted growers lacked accessible toilet facilities.

    High risk
  33. Mena Food Group, LLC

    FDA says Mena Food Group made ready-to-eat bakery products under insanitary conditions and without allergen or CGMP controls.

    High risk
  34. Eurosirel S.P.A

    FDA warns Eurosirel over CGMP failures in topical drugs and pain patches, including missing glycerin identity testing.

    High risk
  35. Hangzhou Huiji Biotechnology Co., Ltd.

    FDA warned Hangzhou Huiji Biotechnology over CGMP failures in OTC hand sanitizers, including missing glycerin and ethanol safety tests.

    High risk
  36. Stew Leonard’s Holdings LLC

    Stew Leonard's Danbury, CT bakery cookies were misbranded: labels omitted peanut and egg allergens tied to a consumer death.

    High risk
  37. Maruhachi Muramatsu Inc., Danchi Factory

    FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

    High risk
  38. Adept Medical Ltd.

    Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.

    High risk
  39. Kyokuyo Global Seafoods Co. LTD.

    FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.

    High risk
  40. Procesadora Vikingo C.A.

    FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.

    High risk
  41. Colgate-Palmolive/Tom's of Maine, Inc.

    FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.

    High risk
  42. Multaler et Cie SAS

    FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.

    High risk
  43. Owens & Minor, Inc. dba American Contract Systems, Inc.

    FDA warned Owens & Minor unit American Contract Systems over device quality-system violations for sterile kits, including failed sterilization bags and incomplete design verification.

    High risk
  44. Rongcheng Jiayuan Food Co., Ltd

    FDA says Rongcheng Jiayuan's canned tuna is adulterated due to seafood HACCP and low-acid canned food violations.

    High risk
  45. Rolence Ent. Inc.

    FDA warns Rolence Ent. Inc. over quality system and MDR failures for its XR-01 Portable X-ray System.

    High risk
  46. Top Health Manufacturing, LLC

    Top Health Manufacturing's dietary supplements violated manufacturing and labeling rules, FDA says.

    Medium
  47. Omni Lens Pvt. Ltd.

    FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.

    High risk
  48. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  49. Hemarus LLC

    Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.

    High risk
  50. Outin Futures Corp.

    FDA warned Outin Futures, a Korean drug manufacturer, of CGMP violations and sunscreen misbranding after a March 2024 inspection.

    High risk